Search research articles
Contact Us
Filters
Showing results (81-90 of 118) with videos related to
Page
of 12
Sort By:
Biorxiv : the Preprint Server for Biology
|
February 6, 2026
Reduced late endosome/lysosome function promotes SLE through chronic PI3k activity and SHP-1/SHIP-1 defects
SunAh Kang, Andrew J Monteith, Liubov Arbeeva, et al.
Scientific Reports
|
May 19, 2026
Tissue transcriptional programs stratify Crohn's disease by therapeutic response and clinical outcomes
Ayesh Awad, Benjamin Huan, Michael T Shanahan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 21, 2014
NFIL3-deficient mice develop microbiota-dependent, IL-12/23-driven spontaneous colitis
Taku Kobayashi, Erin C Steinbach, Steven M Russo, et al.
Gastroenterology
|
December 26, 2012
Carbon monoxide and heme oxygenase-1 prevent intestinal inflammation in mice by promoting bacterial clearance
Joseph C Onyiah, Shehzad Z Sheikh, Nitsan Maharshak, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 18, 2014
Innate PI3K p110δ regulates Th1/Th17 development and microbiota-dependent colitis
Erin C Steinbach, Taku Kobayashi, Steven M Russo, et al.
JCI Insight
|
February 22, 2024
Aberrant miR-29 is a predictive feature of severe phenotypes in pediatric Crohn's disease
Alexandria J Shumway, Michael T Shanahan, Emilie Hollville, et al.
Scientific Reports
|
February 1, 2024
Linking gene expression to clinical outcomes in pediatric Crohn's disease using machine learning
Kevin A Chen, Nina C Nishiyama, Meaghan M Kennedy Ng, et al.
Cell Reports
|
February 3, 2015
Ancient transposable elements transformed the uterine regulatory landscape and transcriptome during the evolution of mammalian pregnancy
Vincent J Lynch, Mauris C Nnamani, Aurélie Kapusta, et al.
Immunotherapy
|
February 25, 2025
Part B of the LILAC study of litifilimab for cutaneous lupus erythematosus: a plain language summary
Victoria P Werth, Richard A Furie, Juanita Romero-Diaz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 17, 2023
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co-Expression Patterns: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
Joan T Merrill, Joel Guthridge, Miles Smith, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 118) with videos related to
Sort By:
Page
of 12
Biorxiv : the Preprint Server for Biology
|
February 6, 2026
Reduced late endosome/lysosome function promotes SLE through chronic PI3k activity and SHP-1/SHIP-1 defects
SunAh Kang, Andrew J Monteith, Liubov Arbeeva, et al.
Scientific Reports
|
May 19, 2026
Tissue transcriptional programs stratify Crohn's disease by therapeutic response and clinical outcomes
Ayesh Awad, Benjamin Huan, Michael T Shanahan, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 21, 2014
NFIL3-deficient mice develop microbiota-dependent, IL-12/23-driven spontaneous colitis
Taku Kobayashi, Erin C Steinbach, Steven M Russo, et al.
Gastroenterology
|
December 26, 2012
Carbon monoxide and heme oxygenase-1 prevent intestinal inflammation in mice by promoting bacterial clearance
Joseph C Onyiah, Shehzad Z Sheikh, Nitsan Maharshak, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 18, 2014
Innate PI3K p110δ regulates Th1/Th17 development and microbiota-dependent colitis
Erin C Steinbach, Taku Kobayashi, Steven M Russo, et al.
JCI Insight
|
February 22, 2024
Aberrant miR-29 is a predictive feature of severe phenotypes in pediatric Crohn's disease
Alexandria J Shumway, Michael T Shanahan, Emilie Hollville, et al.
Scientific Reports
|
February 1, 2024
Linking gene expression to clinical outcomes in pediatric Crohn's disease using machine learning
Kevin A Chen, Nina C Nishiyama, Meaghan M Kennedy Ng, et al.
Cell Reports
|
February 3, 2015
Ancient transposable elements transformed the uterine regulatory landscape and transcriptome during the evolution of mammalian pregnancy
Vincent J Lynch, Mauris C Nnamani, Aurélie Kapusta, et al.
Immunotherapy
|
February 25, 2025
Part B of the LILAC study of litifilimab for cutaneous lupus erythematosus: a plain language summary
Victoria P Werth, Richard A Furie, Juanita Romero-Diaz, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 17, 2023
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co-Expression Patterns: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
Joan T Merrill, Joel Guthridge, Miles Smith, et al.
Page
of 12